Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis (Q37975229)

26 August 2017

0 references

Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis (English)

1 reference

26 August 2017

0 references

1 reference

1 reference

5

Iñaki Lete

0 references

author name string

Francisca Martínez

1

1 reference

26 August 2017

Isabel Ramírez

2

1 reference

26 August 2017

Ezequiel Pérez-Campos

3

1 reference

26 August 2017

Kepa Latorre

4

1 reference

26 August 2017

1 February 2012

1 reference

The European Journal of Contraception Reproductive Health Care

26 August 2017

1 reference

26 August 2017

17

1 reference

26 August 2017

7-29

1 reference

26 August 2017

1

1 reference

Range of published estimates of venous thromboembolism incidence in young women

26 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Mortality in relation to oral contraceptive use and cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Third generation oral contraceptives and risk of venous thrombosis: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

A note on graphical presentation of estimated odds ratios from several clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Oral contraceptives and venous thromboembolic disease. Analyses of the UK General Practice Research Database and the UK Mediplus database

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Oral contraceptives and venous thromboembolism: a five-year national case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Oral contraceptives and fatal pulmonary embolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Population-based study of risk of venous thromboembolism associated with various oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Hormonal contraception and risk of venous thromboembolism: national follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Hemostatic effects of third- and second-generation oral contraceptives: absence of a causal mechanism for a difference in risk of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation "pill scare".

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Thromboembolism associated with the new contraceptive Yasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 microg ethinyl estradiol and a reference containing desogestrel and 30 microg ethinyl estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Effects of switching from oral to transdermal or transvaginal contraception on markers of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Sex hormone--binding globulin--a surrogate marker for the prothrombotic effects of combined oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

The association between extrinsic activated protein C resistance and venous thromboembolism in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

Oral contraceptives and thrombotic diseases: Impact of new epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2011.643836

10.3109/13625187.2011.643836

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference